Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 04 Sept 2026 for Veracyte, INC., €140k. Read the official filing
Filing timeline
BuySaleRebecca Chambers
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Rebecca Chambers: trading record in brief
Rebecca Chambers, listed as finance chief, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Veracyte, Inc., Inari Medical, Inc. and Outset Medical, Inc. Between 25 May 2021 and 4 September 2026, the trades on record add up to 43 filings.
No open-market purchase appears, only 10 sales worth €1.3M. Besides market trades, the filings include 30 share grants and 2 option exercises. Since January 2026: no purchases and 5 sales on the market.
The record was last updated on 4 September 2026 with an open-market sale (€91k) in Veracyte, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rebecca Chambers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations43 total
3,603 shares@ US$44.88Common StockSEC:0001823563-26-000016:0
2,477 shares@ US$42.8059Common StockSEC:0001823563-26-000016:1
1,175 shares@ US$43.714Common StockSEC:0001823563-26-000016:2
3,693 shares@ US$47.800.0054% mcap9.4% of flowCommon StockSEC:0001823563-26-000014:0
1,600 shares@ US$49.28360.0024% mcap4.2% of flowCommon StockSEC:0001823563-26-000014:1
1,961 shares@ US$50.09130.0030% mcap5.2% of flowCommon StockSEC:0001823563-26-000014:2
36,181 shares0Common StockSEC:0001823563-26-000008:0
4,400 shares@ US$35.54765.1% of flowCommon StockSEC:0001823563-26-000006:0
7,234 shares@ US$36.018.4% of flowCommon StockSEC:0001823563-26-000004:0
59,324 shares0Common StockSEC:0001823563-26-000002:0
3,384 shares@ US$46.165.9% of flowCommon StockSEC:0001823563-25-000007:0
7,000 shares@ US$41.0011.7% of flowCommon StockSEC:0001823563-25-000005:0
5,371 shares@ US$30.117.4% of flowCommon StockSEC:0001384101-25-000122:0
5,370 shares@ US$26.747.2% of flowCommon StockSEC:0001384101-25-000071:0
30,200 shares0Common StockSEC:0001384101-25-000043:0
23,170 shares0Common StockSEC:0001384101-25-000022:0
9,684 sharesCommon StockSEC:0001127602-25-005730:0
527 shares@ US$43.851.7% of flowCommon StockSEC:0001384101-25-000006:0
3,464 shares@ US$44.1211.0% of flowCommon StockSEC:0001384101-24-000180:0
15,275 shares@ US$38.341341.6% of flowCommon StockSEC:0001384101-24-000166:0
3,464 shares@ US$31.557.5% of flowCommon StockSEC:0001384101-24-000151:0
260 shares@ US$45.995.2% of flowCommon StockSEC:0001127602-24-019169:0
3,462 shares@ US$20.755.0% of flowCommon StockSEC:0001384101-24-000079:0
964 shares@ US$45.3918.7% of flowCommon StockSEC:0001127602-24-016184:0
4,126 shares@ US$42.4176.1% of flowCommon StockSEC:0001127602-24-013465:0
25 of 43 declarations
